We and others have reported that allosteric inhibitors of GLS, including 968, BPTES, CB839, and UPGL00004 (designated as UP4 from hereon) block cancer cell proliferation (25), (32), with CB839 being examined in a number of clinical trials as an anti-cancer drug (26, 33, 34). The gene discussed is GLS; the disease is cancer.